X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
1. Bretylate
2. Bretylium Tosilate
3. Bretylol
4. Ornid
1. 61-75-6
2. Bretylol
3. Bretylium Tosilate
4. Bretylate
5. Ornid
6. Darenthin
7. N-(2-bromobenzyl)-n,n-dimethylethanaminium 4-methylbenzenesulfonate
8. Darentin
9. Bretylan
10. Bretylium (tosylate)
11. Bretylium P-toluenesulfonate
12. Asl-603
13. Bretylii Tosilas
14. Tosilato De Bretilio
15. Tosilate De Bretylium
16. (o-bromobenzyl)ethyldimethylammonium P-toluenesulfonate
17. Nsc-62164
18. Bretylium Tosilate [inn]
19. 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium 4-methylbenzenesulfonate
20. Dimethylethyl-o-bromobenzylammonium-p-toluenesulphonate
21. N-ethyl-n-o-bromobenzyl-n,n-dimethylammonium Tosylate
22. Benzenemethanaminium, 2-bromo-n-ethyl-n,n-dimethyl-, Salt With 4-methylbenzenesulfonic Acid (1:1)
23. Mls000028635
24. Chebi:3173
25. 78zp3yr353
26. Cas-61-75-6
27. Ncgc00016119-02
28. Asl 603
29. Smr000058647
30. Bretylium Tosilate (inn)
31. Bretilio Tosilato
32. Bretilio Tosilato [dcit]
33. Nsc 62164
34. Bretylii Tosilas [inn-latin]
35. Nsc62164
36. Bretylium Tosylate In Dextrose 5%
37. Sr-01000000254
38. Tosilate De Bretylium [inn-french]
39. Tosilato De Bretilio [inn-spanish]
40. Einecs 200-516-8
41. Bretylium Tosylate (usp)
42. Bretylium Tosylate In Plastic Container
43. Unii-78zp3yr353
44. Bretylium Tosylate [usan:usp]
45. Bretyliume Tosylate
46. Bretylol (tn)
47. Bretylium Tosylate In Dextrose 5% In Plastic Container
48. Opera_id_1513
49. Lopac-b-8406
50. Dsstox_cid_2685
51. Benzenemethanaminium, 2-bromo-n-ethyl-n,n-dimethyl-, Salt With 4-methylbenzenesulfonic Acid
52. Dsstox_rid_76691
53. Dsstox_gsid_22685
54. Schembl40898
55. Bretylium Tosylate [mi]
56. Chembl1095292
57. Dtxsid1022685
58. Bretylium Tosylate [usan]
59. Bretylium Tosylate [vandf]
60. Hms1570n06
61. Hms2097n06
62. Hms2235i21
63. Hms3714n06
64. Bretylium Tosilate [mart.]
65. Ammonium, (o-bromobenzyl)ethyldimethyl-, P-toluenesulfonate
66. Bretylium Tosilate [who-dd]
67. Bretylium Tosylate [usp-rs]
68. Tox21_110308
69. (2-bromophenyl)methyl-ethyl-dimethylazanium;4-methylbenzenesulfonate
70. Hy-12961a
71. Mfcd00038731
72. Akos015842525
73. Ccg-204319
74. Cs-5728
75. Bretylium Tosylate [orange Book]
76. Ncgc00016119-01
77. Ncgc00016119-03
78. Ncgc00016119-04
79. Ncgc00024457-02
80. As-56957
81. Bretylium Tosylate [usp Monograph]
82. Wln: Er B1k2&1&1 &oswr D1
83. Bretylium Tosylate, >99% (tlc), Powder
84. (2-bromobenzyl)ethyldimethylammonium Tosylate
85. Eu-0100224
86. Ft-0603258
87. B 8406
88. D00645
89. Sr-01000000254-2
90. Sr-01000000254-5
91. Q27105972
92. (2-bromobenzyl)ethyldimethylammonium Toluene-4-sulfonate
93. (o-bromobenzyl)ethyldimethylammonium P-toluenesulphonate
94. N-(2-bromobenzyl)-n,n-dimethylethanaminium4-methylbenzenesulfonate
95. [(2-bromophenyl)methyl](ethyl)dimethylazanium 4-methylbenzene-1-sulfonate
96. 2-bromo-n-ethyl-n,n-dimethylbenzenemethanaminium 4-methyl-benzenesulfontate
97. Bretylium Tosylate, United States Pharmacopeia (usp) Reference Standard
98. N-[(2-bromophenyl)methyl]-n,n-dimethylethanaminium 4-methylbenzenesulfonate
99. Benzenemethanaminium,n-dimethyl-, Salt With 4-methylbenzenesulfonic Acid (1:1)
| Molecular Weight | 414.4 g/mol |
|---|---|
| Molecular Formula | C18H24BrNO3S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 413.06603 g/mol |
| Monoisotopic Mass | 413.06603 g/mol |
| Topological Polar Surface Area | 65.6 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 349 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic Antagonists
Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01B - Antiarrhythmics, class i and iii
C01BD - Antiarrhythmics, class iii
C01BD02 - Bretylium tosilate
Market Place
